Barcelona 2022

---

Evolving questions in chronic obstructive pulmonary disease management

Symposium
Chairs: O. Usmani (London, United Kingdom), A. Yorgancioglu (Konak, Turkey), D. Stolz (Basel, Switzerland)
Aims: to ask challenging questions faced every day when managing patients with chronic obstructive pulmonary disease (COPD); to inform clinicians and researchers about the latest updates concerning diagnosis, management and assessment of COPD covering four areas, namely, the role of eosinophils, the pathophysiology of a disease exacerbation, the relevance of mortality endpoints and the assessment of COPD patients for comorbidities; to interpret and elaborate on recent findings of clinical trials and their relevance to patient practice.

Understanding the role of eosinophilic COPD management: are clinical trial data ready for application in everyday clinical care? M. Bafadhel (London, United Kingdom)
What is the best definition of an exacerbation in COPD patients to help demystify clinical trial data? A. Papi (Cona, Ferrara, Italy)
Mortality and mortality assessment in COPD: is it possible to apply clinical trial data in everyday patient practice? D. Singh (Manchester, United Kingdom)
Should all patients with COPD undergo body plethysmography, echocardiograms and computed tomography lung scans? M. Han (Ann Arbor, United States)
Discussion and Q&A